Azimuth Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
NAMA
Azimuth Capital Management's CDNA Position: Q1 2022 in Review
Azimuth Capital Management increased its CareDx (CDNA) stake by 388% in Q1 2022, buying an estimated $6.16M and bringing the position to 198,681 shares worth $7.35M. The position accounts for 0.31% of the portfolio, ranked #122.
Azimuth Capital Management first reported a position in CDNA in Q1 2021 and has held it in 5 quarters since. The position peaked at $11.1M in Q2 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.
- Azimuth Capital Management held 198,681 shares of CareDx worth $7.35M as of Q1 2022.
- Azimuth Capital Management bought 157,990 CareDx shares in Q1 2022, an estimated $6.16M.
- CareDx made up 0.31% of Azimuth Capital Management's portfolio in Q1 2022, its #122 holding.
- Azimuth Capital Management first reported a position in CareDx in Q1 2021 and has held it in 5 quarters since.
- Azimuth Capital Management's CareDx position peaked at $11.1M in Q2 2021.
- 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.
Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.